On September 15th Soligenix, Inc. (SNGX) announced that its Phase 3 clinical trial study of orBec to be stopped because it is highly unlikely to achieve the predetermined primary objective of efficacy based on the interim results. Disappointed news for Soligenix after all these years of orBec’s studies, isn’t it? Market reaction was expected – […]
Home» Posts tagged "SNGX"
Penny Stock Gainers (OTC Bulletin Board) – Dec. 22nd, 2010
12.22.2010 Symbol Company Name Last Net Change % Chg $ Volume Volume PYMX POLYMEDIX 1.08 0.206 23.57% $739,161 760379 NEOM NEOMEDIA TECHNOLOGIES INC 0.195 0.065 50.00% $353,605 1944178 SNGX SOLIGENIX 0.17 0.02 13.33% $312,100 1819836 FLTT FLINT TELECOM GROUP 0.0017 0.0004 30.77% $247,898 136758769 FCCN […]